107 related articles for article (PubMed ID: 26072217)
1. microRNA-365-targeted nuclear factor I/B transcriptionally represses cyclin-dependent kinase 6 and 4 to inhibit the progression of cutaneous squamous cell carcinoma.
Zhou L; Wang Y; Ou C; Lin Z; Wang J; Liu H; Zhou M; Ding Z
Int J Biochem Cell Biol; 2015 Aug; 65():182-91. PubMed ID: 26072217
[TBL] [Abstract][Full Text] [Related]
2. miR-365 promotes cutaneous squamous cell carcinoma (CSCC) through targeting nuclear factor I/B (NFIB).
Zhou M; Zhou L; Zheng L; Guo L; Wang Y; Liu H; Ou C; Ding Z
PLoS One; 2014; 9(6):e100620. PubMed ID: 24949940
[TBL] [Abstract][Full Text] [Related]
3. miR-9 induces cell arrest and apoptosis of oral squamous cell carcinoma via CDK 4/6 pathway.
Shang A; Lu WY; Yang M; Zhou C; Zhang H; Cai ZX; Wang WW; Wang WX; Wu GQ
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1754-1762. PubMed ID: 29073835
[TBL] [Abstract][Full Text] [Related]
4. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways.
Lin SL; Chang DC; Ying SY; Leu D; Wu DT
Cancer Res; 2010 Nov; 70(22):9473-82. PubMed ID: 21062975
[TBL] [Abstract][Full Text] [Related]
6. miR-193b/365a cluster controls progression of epidermal squamous cell carcinoma.
Gastaldi C; Bertero T; Xu N; Bourget-Ponzio I; Lebrigand K; Fourre S; Popa A; Cardot-Leccia N; Meneguzzi G; Sonkoly E; Pivarcsi A; Mari B; Barbry P; Ponzio G; Rezzonico R
Carcinogenesis; 2014 May; 35(5):1110-20. PubMed ID: 24374827
[TBL] [Abstract][Full Text] [Related]
7. miR-125b can enhance skin tumor initiation and promote malignant progression by repressing differentiation and prolonging cell survival.
Zhang L; Ge Y; Fuchs E
Genes Dev; 2014 Nov; 28(22):2532-46. PubMed ID: 25403182
[TBL] [Abstract][Full Text] [Related]
8. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.
Sand M; Skrygan M; Georgas D; Sand D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
J Dermatol Sci; 2012 Dec; 68(3):119-26. PubMed ID: 23026055
[TBL] [Abstract][Full Text] [Related]
9. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular cdks.
Upton JW; van Dyk LF; Speck SH
Virology; 2005 Oct; 341(2):271-83. PubMed ID: 16102793
[TBL] [Abstract][Full Text] [Related]
10. Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells.
Chilampalli C; Guillermo R; Kaushik RS; Young A; Chandrasekher G; Fahmy H; Dwivedi C
Exp Biol Med (Maywood); 2011 Nov; 236(11):1351-9. PubMed ID: 21908486
[TBL] [Abstract][Full Text] [Related]
11. MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression.
Toll A; Salgado R; Espinet B; Díaz-Lagares A; Hernández-Ruiz E; Andrades E; Sandoval J; Esteller M; Pujol RM; Hernández-Muñoz I
Mol Cancer; 2016 Jul; 15(1):53. PubMed ID: 27457246
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
13. Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines.
Timmermann S; Hinds PW; Münger K
Cell Growth Differ; 1997 Apr; 8(4):361-70. PubMed ID: 9101082
[TBL] [Abstract][Full Text] [Related]
14. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
Johnson DG
Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
[TBL] [Abstract][Full Text] [Related]
15. Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present.
Casimiro MC; Velasco-Velázquez M; Aguirre-Alvarado C; Pestell RG
Expert Opin Investig Drugs; 2014 Mar; 23(3):295-304. PubMed ID: 24387133
[TBL] [Abstract][Full Text] [Related]
16. Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6.
Laman H; Funes JM; Ye H; Henderson S; Galinanes-Garcia L; Hara E; Knowles P; McDonald N; Boshoff C
EMBO J; 2005 Sep; 24(17):3104-16. PubMed ID: 16096642
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D.
Georgantas RW; Streicher K; Luo X; Greenlees L; Zhu W; Liu Z; Brohawn P; Morehouse C; Higgs BW; Richman L; Jallal B; Yao Y; Ranade K
Pigment Cell Melanoma Res; 2014 Mar; 27(2):275-86. PubMed ID: 24289491
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C epsilon, which sensitizes skin to sun's UV radiation-induced cutaneous damage and development of squamous cell carcinomas, associates with Stat3.
Aziz MH; Manoharan HT; Verma AK
Cancer Res; 2007 Feb; 67(3):1385-94. PubMed ID: 17283176
[TBL] [Abstract][Full Text] [Related]
19. microRNA-26a and -584 inhibit the colorectal cancer progression through inhibition of the binding of hnRNP A1-CDK6 mRNA.
Konishi H; Fujiya M; Ueno N; Moriichi K; Sasajima J; Ikuta K; Tanabe H; Tanaka H; Kohgo Y
Biochem Biophys Res Commun; 2015 Nov; 467(4):847-52. PubMed ID: 26494299
[TBL] [Abstract][Full Text] [Related]
20. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
